Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides

C. de Wolf, R. Jansen, H. Yamaguchi, M. de Haas, K. van de Wetering, J. Wijnholds, J. Beijnen, P. Borst
  • Molecular Cancer Therapeutics, September 2008, American Association for Cancer Research (AACR)
  • DOI: 10.1158/1535-7163.mct-08-0427

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Robert Jansen